Novavax, Inc.

BMV:NVAX * Stock Report

Market Cap: Mex$28.4b

Novavax Future Growth

Future criteria checks 3/6

Novavax's revenue is forecast to decline at 10.2% per annum while its annual earnings are expected to grow at 67% per year. EPS is expected to grow by 72.7% per annum.

Key information

67.0%

Earnings growth rate

72.7%

EPS growth rate

Biotechs earnings growth0%
Revenue growth rate-10.2%
Future return on equityn/a
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:NVAX * - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267512341522863
12/31/202555776164166
12/31/2024684-225-218-676
9/30/2024885-285-112-91N/A
6/30/2024988-294-2414N/A
3/31/2024997-399-514-472N/A
12/31/2023984-545-773-714N/A
9/30/20231,050-549-727-655N/A
6/30/20231,597-587-737-654N/A
3/31/20231,359-1,155-753-653N/A
12/31/20221,982-658-509-416N/A
9/30/20221,847-1,322-728-641N/A
6/30/20221,291-1,476-814-744N/A
3/31/20221,403-1,318-489-429N/A
12/31/20211,146-1,744265323N/A
9/30/20211,204-1,075454537N/A
6/30/20211,182-950593672N/A
3/31/2021919-615575644N/A
12/31/2020476-418-97-43N/A
9/30/2020205-2734962N/A
6/30/202050-933237N/A
3/31/202018-115-110-109N/A
12/31/201919-133-138-137N/A
9/30/201916-150-160-158N/A
6/30/201921-177-162-159N/A
3/31/201929-182-171-169N/A
12/31/201834-185-186-185N/A
9/30/201839-186-184-183N/A
6/30/201839-186N/A-194N/A
3/31/201835-186N/A-166N/A
12/31/201731-184N/A-144N/A
9/30/201726-190N/A-162N/A
6/30/201721-212N/A-181N/A
3/31/201717-247N/A-230N/A
12/31/201615-280N/A-259N/A
9/30/201616-302N/A-249N/A
6/30/201619-269N/A-215N/A
3/31/201631-210N/A-165N/A
12/31/201536-157N/A-126N/A
9/30/201537-110N/A-91N/A
6/30/201539-96N/A-78N/A
3/31/201533-94N/A-77N/A
12/31/201431-83N/A-67N/A
9/30/201433-65N/A-60N/A
6/30/201429-61N/A-59N/A
3/31/201425-56N/A-55N/A
12/31/201321-52N/A-45N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NVAX * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.1%).

Earnings vs Market: NVAX * is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NVAX * is expected to become profitable in the next 3 years.

Revenue vs Market: NVAX *'s revenue is expected to decline over the next 3 years (-10.2% per year).

High Growth Revenue: NVAX *'s revenue is forecast to decline over the next 3 years (-10.2% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NVAX *'s Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y